Frontage Labs plans expansion of CMC facility

Thursday, June 5, 2014 09:00 AM

Frontage Labs plans to expand its chemistry, manufacturing and controls (CMC) facility in Exton, Pa., to significant increase capacity to existing services and provide additional room for future growth.

More... »

Tigermed takes majority stake in Frontage Labs

Tuesday, May 13, 2014 01:50 PM

Chinese CRO Hangzhou Tigermed Consulting, through its subsidiary Hong Kong Tigermed, will acquire a majority ownership position in Exton, Pa.-based Frontage Laboratories for $50.25 million in cash.  

More... »

Frontage Laboratories names new head of global CMC services

Wednesday, July 24, 2013 09:43 AM

Frontage Laboratories has appointed Dr. Cheryl Li senior vice president, Global CMC Services.  The division offers an integrated service portfolio ranging from dosage form product development, contract manufacturing, pharmaceutical analysis and organic syntheses to CMC strategy consulting. Li’s position is an initial step of Frontage’s corporate strategic expansion in CMC infrastructure to meet growing development needs in novel drugs, generic products and biosimilars.

More... »

Frontage Laboratories makes two senior appointments

Thursday, July 18, 2013 10:30 AM

George Laskaris and Alma Villasin have joined Frontage Laboratories in senior positions. Laskaris has been named senior director, Frontage Biometrics Services, and Villasin, R.N., B.S.N., M.B.A., joins as director, clinical operations.

More... »

Frontage to develop AtheroNova clinical trial supplies

Friday, April 27, 2012 11:59 AM

Frontage, a global CRO based in Ecton, Penn., has signed an agreement to develop clinical trial supplies with AtheroNova, a biotech company focused on R&D of compounds to regress atherosclerotic plaque.

More... »

CRO Frontage and Fanghui Pharma launch collaboration

Thursday, February 23, 2012 02:42 PM

An emerging Chinese pharmaceutical company just launched a new globalization strategy by tapping the pharmaceutical R&D, manufacturing, registration and marketing expertise of global CRO Frontage Laboratories.

More... »

Tang joins ICON Development Solutions

Monday, November 28, 2011 11:29 AM

ICON's Development Solutions division has named Dr. Daniel Tang general manager, Asia Pacific. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.

More... »

Spaulding, Frontage partner in clinical development

Tuesday, September 13, 2011 01:37 PM

Spaulding Clinical Research, the US-based provider of clinical pharmacology and cardiac core-laboratory services is extending its reach further east through an alliance with Frontage Laboratories, according to PharmaTimes.

More... »

Frontage Laboratories collaborates with Yabao Pharmaceuticals Group

Tuesday, March 1, 2011 08:00 AM

Frontage Laboratories has signed a $50 million collaboration with China’s Yabao Pharmaceuticals Group, under which Frontage will supply pharmaceutical and regulatory development services to Yabao over five years, according to PharmaTimes.

More... »

CenterWatch Data Library



Browse by:


December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs